This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

November 24, 2025

Study Completion Date

November 24, 2028

Conditions
Recurrent Prostate Cancer After Surgery
Interventions
RADIATION

Daily-adaptive Stereotactic Body Radiation Therapy

Daily-adaptive radiation therapy to two dose levels - one to the area of radiologic recurrent nodal disease, and a lower, prophylactic dose to the standard post-prostatectomy and larger pelvic node fields

RADIATION

Daily-adaptive Stereotactic Body Radiation Therapy

Daily-adaptive radiation therapy to two areas - a high dose to the area of radiologic recurrence, and a lower, prophylactic dose to the standard post-prostatectomy fields

Trial Locations (1)

14624

RECRUITING

Wilmot Cancer Institute - Dept of Radiation Oncology, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

University of Rochester

OTHER